{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:59:48Z","timestamp":1767974388561,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"DOI":"10.1007\/s12328-021-01417-3","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T04:04:25Z","timestamp":1618977865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Small bowel T-cell lymphoma: a MEITL-ing diagnosis"],"prefix":"10.1007","author":[{"given":"Sheena","family":"Mago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Mavilia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faripour","family":"Forouhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleh","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"1417_CR1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.17219\/acem\/94068","volume":"28","author":"M Olszewska-Szopa","year":"2019","unstructured":"Olszewska-Szopa M, Wr\u00f3bel T. Gastrointestinal non-Hodgkin lymphomas. Adv Clin Exp Med. 2019;28:1119\u201324.","journal-title":"Adv Clin Exp Med"},{"key":"1417_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/1471-2407-11-321","volume":"11","author":"SJ Kim","year":"2011","unstructured":"Kim SJ, Choi CW, Mun YC, et al. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the consortium for improving survival of lymphoma (CISL). BMC Cancer. 2011;11:321.","journal-title":"BMC Cancer"},{"key":"1417_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","volume":"118","author":"J Delabie","year":"2011","unstructured":"Delabie J, Holte H, Vose JM, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood. 2011;118:148\u201355.","journal-title":"Blood"},{"key":"1417_CR4","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390.","journal-title":"Blood"},{"key":"1417_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1443-1661.2010.00989.x","volume":"22","author":"Y Sato","year":"2010","unstructured":"Sato Y, Ono M, Sagawa T, et al. Endoscopic findings of enteropathy-type T-cell lymphoma by double-balloon enteroscopy and capsule endoscopy. Dig Endosc. 2010;22:243\u20135.","journal-title":"Dig Endosc"},{"key":"1417_CR6","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3109\/10428194.2012.656633","volume":"53","author":"Y Kakugawa","year":"2012","unstructured":"Kakugawa Y, Terasaka S, Watanabe T, et al. Enteropathy-associated T-cell lymphoma in small intestine detected by capsule endoscopy. Leuk Lymphoma. 2012;53:1623\u20134.","journal-title":"Leuk Lymphoma"},{"key":"1417_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4322\/acr.2012.014","volume":"2","author":"A Felipe-Silva","year":"2012","unstructured":"Felipe-Silva A, de Campos FPF, de Medeiros RSS, et al. Enteropathy-associated T-cell lymphoma (type II): a Brazilian case report. Autops Case Rep. 2012;2:31\u20136.","journal-title":"Autops Case Rep"},{"key":"1417_CR8","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3748\/wjg.v18.i19.2434","volume":"18","author":"K Okumura","year":"2012","unstructured":"Okumura K, Ikebe M, Shimokama T, et al. An unusual enteropathy-associated T-cell lymphoma with MYC translocation arising in a Japanese patient: a case report. World J Gastroenterol. 2012;18:2434\u20137.","journal-title":"World J Gastroenterol"},{"key":"1417_CR9","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1007\/s11605-012-1878-6","volume":"16","author":"Y Yang","year":"2012","unstructured":"Yang Y, Batth SS, Chen M, et al. Enteropathy-associated T cell lymphoma presenting with acute abdominal syndrome: a case report and review of literature. J Gastrointest Surg. 2012;16:1446\u20139.","journal-title":"J Gastrointest Surg"},{"key":"1417_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.gie.2013.02.033","volume":"78","author":"M Fukushima","year":"2013","unstructured":"Fukushima M, Kawanami C, Inoue S, et al. Enteropathy-associated T-cell lymphoma diagnosed and followed-up by using double-balloon enteroscopy. Gastrointest Endosc. 2013;78:361\u20132 (discussion 363).","journal-title":"Gastrointest Endosc."},{"key":"1417_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13000-016-0519-x","volume":"11","author":"H Ishibashi","year":"2016","unstructured":"Ishibashi H, Nimura S, Kayashima Y, et al. Multiple lesions of gastrointestinal tract invasion by monomorphic epitheliotropic intestinal T-cell lymphoma, accompanied by duodenal and intestinal enteropathy-like lesions and microscopic lymphocytic proctocolitis: a case series. Diagn Pathol. 2016;11:66.","journal-title":"Diagn Pathol"},{"key":"1417_CR12","first-page":"88","volume":"71","author":"CC Liong","year":"2016","unstructured":"Liong CC, Ravindran S, Gnana Kumar G, et al. Enteropathy-associated T-cell lymphoma: an extremely rare cause of chronic diarrhoea. Med J Malaysia. 2016;71:88\u201390.","journal-title":"Med J Malaysia"},{"key":"1417_CR13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/hon.2288","volume":"35","author":"Y Chen","year":"2017","unstructured":"Chen Y, Tan SY, Petersson BF, et al. Occult recurrence of monomorphic epitheliotropic intestinal T-cell lymphoma and the role of MATK gene expression in diagnosis. Hematol Oncol. 2017;35:852\u20135.","journal-title":"Hematol Oncol"},{"key":"1417_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3332\/ecancer.2017.771","volume":"11","author":"C Gentille","year":"2017","unstructured":"Gentille C, Qin Q, Barbieri A, et al. Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges. Ecancermedicalscience. 2017;11:771.","journal-title":"Ecancermedicalscience"},{"key":"1417_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/cup.12864","volume":"44","author":"K Aiempanakit","year":"2017","unstructured":"Aiempanakit K, Amatawet C, Chiratikarnwong K, et al. Erythema multiforme-like cutaneous lesions in monomorphic epitheliotropic intestinal T-cell lymphoma: a rare case report. J Cutan Pathol. 2017;44:183\u20138.","journal-title":"J Cutan Pathol"},{"key":"1417_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/00365521.2019.1647455","volume":"54","author":"MV Lenti","year":"2019","unstructured":"Lenti MV, Biagi F, Lucioni M, et al. Two cases of monomorphic epitheliotropic intestinal T-cell lymphoma associated with coeliac disease. Scand J Gastroenterol. 2019;54:965\u20138.","journal-title":"Scand J Gastroenterol"},{"key":"1417_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/bjh.16073","volume":"187","author":"C Ikeda","year":"2019","unstructured":"Ikeda C, Maruyama D, Oka H, et al. Bone marrow involvement by monomorphic epitheliotropic intestinal T-cell lymphoma. Br J Haematol. 2019;187:10.","journal-title":"Br J Haematol"},{"key":"1417_CR18","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1182\/blood-2017-11-819136","volume":"131","author":"Y Kubota","year":"2018","unstructured":"Kubota Y, Kusaba K. Monomorphic epitheliotropic intestinal T-cell lymphoma involving the central nervous system. Blood. 2018;131:1765.","journal-title":"Blood"},{"key":"1417_CR19","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.gie.2018.12.009","volume":"89","author":"CK Noh","year":"2019","unstructured":"Noh CK, Roh J, Lee KJ. Monomorphic epitheliotropic intestinal T cell lymphoma presenting in weblike feature. Gastrointest Endosc. 2019;89:891\u20132.","journal-title":"Gastrointest Endosc"},{"key":"1417_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/jgh.14474","volume":"34","author":"R Hashimoto","year":"2019","unstructured":"Hashimoto R, Matsuda T. Gastrointestinal: Endoscopic findings of monomorphic epitheliotropic intestinal T-cell lymphoma. J Gastroenterol Hepatol. 2019;34:311.","journal-title":"J Gastroenterol Hepatol"},{"key":"1417_CR21","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00277-018-3491-6","volume":"98","author":"R Tabata","year":"2019","unstructured":"Tabata R, Tabata C, Okamura M, et al. Successful treatment of monomorphic epitheliotropic intestinal T cell lymphoma with pralatrexate. Ann Hematol. 2019;98:1301\u20133.","journal-title":"Ann Hematol"},{"key":"1417_CR22","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.12998\/wjcc.v8.i7.1278","volume":"8","author":"TZ Liu","year":"2020","unstructured":"Liu TZ, Zheng YJ, Zhang ZW, et al. Chidamide based combination regimen for treatment of monomorphic epitheliotropic intestinal T cell lymphoma following radical operation: two case reports. World J Clin Cases. 2020;8:1278\u201386.","journal-title":"World J Clin Cases"},{"key":"1417_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2020.04.005","author":"G Kasinathan","year":"2020","unstructured":"Kasinathan G. Monomorphic epitheliotropic intestinal T-cell lymphoma of the duodenum: an aggressive disease. Hematol Transfus Cell Ther. 2020. https:\/\/doi.org\/10.1016\/j.htct.2020.04.005.","journal-title":"Hematol Transfus Cell Ther"},{"key":"1417_CR24","doi-asserted-by":"publisher","first-page":"e20050","DOI":"10.1097\/MD.0000000000020050","volume":"99","author":"Z Liu","year":"2020","unstructured":"Liu Z, He L, Jiao Y, et al. Type II enteropathy-associated T cell lymphoma in the duodenum: a rare case report. Medicine. 2020;99:e20050.","journal-title":"Medicine"},{"key":"1417_CR25","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/ajh.23213","volume":"87","author":"E Tse","year":"2012","unstructured":"Tse E, Gill H, Loong F, et al. Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group. Am J Hematol. 2012;87:663\u20138.","journal-title":"Am J Hematol"},{"key":"1417_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","volume":"45","author":"G Malamut","year":"2013","unstructured":"Malamut G, Chandesris O, Verkarre V, et al. Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study. Dig Liver Dis. 2013;45:377\u201384.","journal-title":"Dig Liver Dis"},{"key":"1417_CR27","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00277-019-03791-y","volume":"98","author":"JH Yi","year":"2019","unstructured":"Yi JH, Lee GW, Do YR, et al. Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma. Ann Hematol. 2019;98:2541\u201350.","journal-title":"Ann Hematol"},{"key":"1417_CR28","first-page":"143","volume":"11","author":"DM Cooley","year":"2015","unstructured":"Cooley DM, Walker AJ, Gopal DV. From capsule endoscopy to balloon-assisted deep enteroscopy: exploring small-bowel endoscopic imaging. Gastroenterol Hepatol. 2015;11:143\u201354.","journal-title":"Gastroenterol Hepatol"},{"key":"1417_CR29","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1182\/blood-2012-11-466839","volume":"121","author":"E Jantunen","year":"2013","unstructured":"Jantunen E, Boumendil A, Finel H, et al. Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT. Blood. 2013;121:2529\u201332.","journal-title":"Blood"},{"key":"1417_CR30","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","volume":"116","author":"N Schmitz","year":"2010","unstructured":"Schmitz N, Tr\u00fcmper L, Ziepert M, et al. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood. 2010;116:3418\u201325.","journal-title":"Blood"},{"key":"1417_CR31","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1634\/theoncologist.2015-0043","volume":"20","author":"SP Iyer","year":"2015","unstructured":"Iyer SP, Foss FF. Romidepsin for the treatment of peripheral T-cell lymphoma. Oncologist. 2015;20:1084\u201391.","journal-title":"Oncologist"},{"key":"1417_CR32","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1200\/JCO.2010.29.9024","volume":"29","author":"OA O'Connor","year":"2011","unstructured":"O\u2019Connor OA, Pro B, Pinter-Brown L, et al. Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. J Clin Oncol. 2011;29:1182\u20139.","journal-title":"J Clin Oncol"},{"key":"1417_CR33","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.1200\/jco.2013.31.15_suppl.8507","volume":"31","author":"O O\u2019Connor","year":"2013","unstructured":"O\u2019Connor O, Masszi T, Savage K, et al. Belinostat, a novel pan-histone deacetylase inhibitor (HDACi), in relapsed or refractory peripheral T-cell lymphoma (R\/R PTCL): results from the BELIEF trial. J Clin Oncol. 2013;31:8507 (abstract).","journal-title":"J Clin Oncol"},{"key":"1417_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1177\/2040620715592567","volume":"6","author":"A Sawas","year":"2015","unstructured":"Sawas A, Radeski D, O\u2019Connor OA. Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review. Ther Adv Hematol. 2015;6:202\u20138.","journal-title":"Ther Adv Hematol"},{"key":"1417_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","volume":"393","author":"S Horwitz","year":"2019","unstructured":"Horwitz S, O\u2019Connor OA, Pro B, et al. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet. 2019;393:229\u201340.","journal-title":"Lancet"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-021-01417-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-021-01417-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-021-01417-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T04:30:44Z","timestamp":1618979444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-021-01417-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":35,"alternative-id":["1417"],"URL":"https:\/\/doi.org\/10.1007\/s12328-021-01417-3","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sheena Mago, Marianna Mavilia, Faripour Forouhar, and Haleh Vaziri declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and rights"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}